Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus (Q48799668)

15 February 2018

title

Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus (English)

1 reference

15 February 2018

author name string

Susan R Kirsh

series ordinal

1

1 reference

15 February 2018

David C Aron

series ordinal

2

1 reference

15 February 2018

publication date

1 December 2011

1 reference

15 February 2018

published in

Drugs & Aging

1 reference

15 February 2018

volume

28

1 reference

15 February 2018

issue

12

1 reference

15 February 2018

page(s)

945-960

1 reference

15 February 2018

Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients.

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The burden and treatment of diabetes in elderly individuals in the u.s.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Clinical complexity in middle-aged and older adults with diabetes: the Health and Retirement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Diabetes mellitus in older adults: time for an overtreatment quality indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Long-term effects of intensive glucose lowering on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Diabetes mellitus in the elderly: diagnostic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Appropriate application of evidence to the care of elderly patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Cognitive dysfunction is associated with poor diabetes control in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Impact of diabetes on physical function in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Depression and glycemic control in elderly ethnically diverse patients with diabetes: the IDEATel project

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Care of elderly patients with diabetes mellitus: A focus on frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Antidiabetic oral treatment in older people: does frailty matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Linking glycemic control and executive function in rural older adults with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The relationship between glycemic control and falls in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Falls as a complication of diabetes mellitus in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Complications of diabetes in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Prevalence and costs of major depression among elderly claimants with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Caring for older adults with diabetes mellitus: characteristics of carers and their prime roles and responsibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Medication use leading to emergency department visits for adverse drug events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Individual sulfonylureas and serious hypoglycemia in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Hypoglycaemia and dementia in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

What's wrong with too low? Is hypoglycemia a marker or a cause of CVD and mortality risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

A cardiologist's view of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Incretin-based therapies in complex patients: practical implications and opportunities for maximizing clinical outcomes: a discussion with Dr. Vivian A. Fonseca

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Polypharmacy and Combination Therapy in the Management of Hypertension in Elderly Patients with Co-Morbid Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Glucose control in the older patient: from intensive, to effective and safe

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Comparative effectiveness of guidelines for the management of hyperlipidemia and hypertension for type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Executive summary: standards of medical care in diabetes--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Good clinical practice guidelines for care home residents with diabetes: an executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Goals of glycemic control in frail older patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The effect of treatment based on a diuretic (indapamide) +/- ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

"The lower the BP the better" paradigm in the elderly: vanished by VALISH?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Therapies for diabetic dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Lipid lowering for secondary prevention of cardiovascular disease in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of subgroups by age.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

One size does not fit all: the need for a continuous measure for glycemic control in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Diminishing efficacy of combination therapy, response-heterogeneity, and treatment intolerance limit the attainability of tight risk factor control in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Pr

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Cardiovascular risk assessment scores for people with diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

A shared decision-making primary care intervention for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

The effect of giving global coronary risk information to adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

Diabetes and Incidence of Functional Disability in Older Women

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F11594750-000000000-00000

21 January 2018

12 December 2020

Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12)

1 reference

12 December 2020

Diabetes in elderly adults

1 reference

12 December 2020

Using clinical guidelines designed for older adults with diabetes mellitus and complex health status

1 reference

12 December 2020

Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?

1 reference

12 December 2020

Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: outcome of 6-year prospective study

1 reference

12 December 2020

Reexamining metrics for glucose control

1 reference

12 December 2020

A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes

1 reference

12 December 2020

Postprandial hyperglycemia is an independent risk for retinopathy in elderly patients with type 2 diabetes mellitus, especially in those with near-normal glycosylated hemoglobin

1 reference

12 December 2020

Guidelines for Improving the Care of the Older Person with Diabetes Mellitus

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

Survival in people with type 2 diabetes as a function of HbA(1c)

1 reference

12 December 2020

Know your A1c number or your A1c range? The need to implement glycemic numeracy into policy and practice

1 reference

12 December 2020

Balancing hypoglycemia and glycemic control: a public health approach for insulin safety

1 reference

12 December 2020

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes

1 reference

12 December 2020

Atypical presentation of silent nocturnal hypoglycemia in an older person

1 reference

12 December 2020

Medication usage in an elderly population.

1 reference

12 December 2020

Excess mortality related to diabetes mellitus in elderly medicare beneficiaries*1

1 reference

12 December 2020

Disability and quality of life in elderly people with diabetes.

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Risk of falls associated with antihypertensive medication: population-based case-control study

1 reference

12 December 2020

Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

10.2165/11594750-000000000-00000

Identifiers

DOI

1 reference

15 February 2018

Dimensions Publication ID

1017816440

0 references

1 reference

15 February 2018